Progyny Inc (NASDAQ:PGNY) — Market Cap & Net Worth
Market Cap & Net Worth: Progyny Inc (PGNY)
Progyny Inc (NASDAQ:PGNY) has a market capitalization of $2.01 Billion ($2.01 Billion) as of June 16, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #6323 globally and #1941 in its home market, demonstrating a 4.06% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Progyny Inc's stock price $26.91 by its total outstanding shares 78332370 (78.33 Million). Review PGNY total liabilities to assess the company's total debt and financial obligations.
Progyny Inc Market Cap History: 2019 to 2026
Progyny Inc's market capitalization history from 2019 to 2026. Data shows growth from $2.15 Billion to $2.11 Billion (8.20% CAGR).
Index Memberships
Progyny Inc is a constituent of 3 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.44 Trillion | 0.08% | #154 of 976 |
|
NASDAQ Composite
IXIC
|
$41.39 Trillion | 0.00% | #691 of 3165 |
|
S&P Small-Cap 600 Index
SML
|
$1.65 Trillion | 0.14% | #311 of 602 |
Weight: Progyny Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Progyny Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Progyny Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
1.56x
Progyny Inc's market cap is 1.56 times its annual revenue
Latest Price to Earnings (P/E) Ratio
34.37x
Progyny Inc's market cap is 34.37 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $2.15 Billion | $229.68 Million | -$8.57 Million | 9.36x | N/A |
| 2020 | $3.32 Billion | $344.86 Million | $46.46 Million | 9.63x | 71.47x |
| 2021 | $3.94 Billion | $500.62 Million | $65.77 Million | 7.88x | 59.97x |
| 2022 | $2.44 Billion | $786.91 Million | $30.36 Million | 3.10x | 80.38x |
| 2023 | $2.91 Billion | $1.09 Billion | $62.04 Million | 2.68x | 46.95x |
| 2024 | $1.35 Billion | $1.17 Billion | $54.34 Million | 1.16x | 24.87x |
| 2025 | $2.01 Billion | $1.29 Billion | $58.52 Million | 1.56x | 34.37x |
Competitor Companies of PGNY by Market Capitalization
Companies near Progyny Inc in the global market cap rankings as of June 16, 2026.
Key companies related to Progyny Inc by market ranking:
- UnitedHealth Group Incorporated (NYSE:UNH): Ranked #69 globally with a market cap of $256.27 Billion USD.
- CVS Health Corp (NYSE:CVS): Ranked #254 globally with a market cap of $101.04 Billion USD.
- Elevance Health Inc (NYSE:ELV): Ranked #298 globally with a market cap of $86.69 Billion USD.
- Cigna Corp (NYSE:CI): Ranked #352 globally with a market cap of $77.41 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #69 | UnitedHealth Group Incorporated | NYSE:UNH | $256.27 Billion | $411.04 |
| #254 | CVS Health Corp | NYSE:CVS | $101.04 Billion | $100.68 |
| #298 | Elevance Health Inc | NYSE:ELV | $86.69 Billion | $401.89 |
| #352 | Cigna Corp | NYSE:CI | $77.41 Billion | $293.83 |
Progyny Inc Historical Marketcap From 2019 to 2026
Between 2019 and today, Progyny Inc's market cap moved from $2.15 Billion to $ 2.11 Billion, with a yearly change of 8.20%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.11 Billion | +4.79% |
| 2025 | $2.01 Billion | +48.87% |
| 2024 | $1.35 Billion | -53.60% |
| 2023 | $2.91 Billion | +19.36% |
| 2022 | $2.44 Billion | -38.13% |
| 2021 | $3.94 Billion | +18.78% |
| 2020 | $3.32 Billion | +54.43% |
| 2019 | $2.15 Billion | -- |
End of Day Market Cap According to Different Sources
On Jun 16th, 2026 the market cap of Progyny Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.01 Billion USD |
| MoneyControl | $2.01 Billion USD |
| MarketWatch | $2.01 Billion USD |
| marketcap.company | $2.01 Billion USD |
| Reuters | $2.01 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Progyny Inc
Progyny, Inc., a benefits management company, provides fertility, family building, and women's health benefits solutions in the United States. It offers fertility benefits solutions, such as differentiated benefits plan design that includes smart cycle treatment bundle; personalized concierge-style member support services; and a selective network of fertility specialists. The company also offers … Read more